Antibody Titers against Mpox Virus after Vaccination
N Engl J Med
.
2023 Dec 14;389(24):2299-2301.
doi: 10.1056/NEJMc2306239.
Authors
Angelica C Kottkamp
1
,
Marie I Samanovic
1
,
Ralf Duerr
1
,
Aaron L Oom
1
,
Hayley M Belli
1
,
Jane R Zucker
2
,
Jennifer B Rosen
2
,
Mark J Mulligan
3
;
NYC OSMI Study Group
Collaborators
NYC OSMI Study Group
:
Angelica C Kottkamp
,
Marie I Samanovic
,
Ralf Duerr
,
Aaron L Oom
,
Hayley M Belli
,
Jane R Zucker
,
Jennifer B Rosen
,
Mark J Mulligan
,
Abdul Abdulai
,
Jaqueline Callahan
,
Ellie Carmody
,
Tamia Davis
,
Meike Dittmann
,
Amanda Dontino
,
Aimee Edwin
,
Celia Engelson
,
Olivia Frank
,
Emily Geesey
,
Shelby Goins
,
Sarah Haiken
,
Trishala Karmacharya
,
Dorothy Knutsen
,
Irma Noriega
,
Samuel Nweke
,
Lalitha Parameswaran
,
Gurchetan Randhawa
,
Stephanie Rettig
,
Miguel Rodriguez
,
Austin Schinlever
,
Pamela Suman
,
Meron Tasissa
,
Michael Tuen
,
Heekoung Allison Youn
,
Julia Wagner
,
Jimmy P Wilson
,
Kesi Wilson
,
Samantha Yip
,
Miilani Yonatan
,
Lisa Zhao
Affiliations
1
NYU Grossman School of Medicine, New York, NY angelica.kottkamp@nyulangone.org.
2
New York City Department of Health and Mental Hygiene, New York, NY.
3
NYU Grossman School of Medicine, New York, NY.
PMID:
38091537
PMCID:
PMC10754300
DOI:
10.1056/NEJMc2306239
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Viral* / analysis
Antibodies, Viral* / immunology
Humans
Monkeypox virus* / immunology
Mpox (monkeypox)* / immunology
Mpox (monkeypox)* / prevention & control
Vaccination
Substances
Antibodies, Viral
Grants and funding
75N93021C00014/AI/NIAID NIH HHS/United States
UM1 AI148574/AI/NIAID NIH HHS/United States
75N93021C00014/NH/NIH HHS/United States
AI148574/NH/NIH HHS/United States